KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Net Margin (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Net Margin data on record, last reported at 27.82% in Q4 2025.

  • For Q4 2025, Net Margin fell 630.0% year-over-year to 27.82%; the TTM value through Dec 2025 reached 3.59%, down 385.0%, while the annual FY2025 figure was 3.59%, 385.0% down from the prior year.
  • Net Margin reached 27.82% in Q4 2025 per CRL's latest filing, down from 5.42% in the prior quarter.
  • Across five years, Net Margin topped out at 18.46% in Q4 2023 and bottomed at 27.82% in Q4 2025.
  • Average Net Margin over 5 years is 6.29%, with a median of 8.96% recorded in 2023.
  • Peak YoY movement for Net Margin: surged 267bps in 2022, then plummeted -3997bps in 2024.
  • A 5-year view of Net Margin shows it stood at 15.45% in 2021, then grew by 11bps to 17.19% in 2022, then rose by 7bps to 18.46% in 2023, then plummeted by -217bps to 21.52% in 2024, then decreased by -29bps to 27.82% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 27.82% in Q4 2025, 5.42% in Q3 2025, and 5.07% in Q2 2025.